605177 東亞藥業
按盤價 
20.220 -1.750 (-7.965%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -6.746 | -4.477 | -5.175 | 6.290 | 5.805 |
| 總資產報酬率 ROA (%) | -3.696 | -2.390 | -2.918 | 4.170 | 4.422 |
| 投入資產回報率 ROIC (%) | -4.254 | -2.791 | -3.363 | 4.781 | 5.098 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.883 | 23.620 | 27.755 | 26.640 | 22.818 |
| 營業利潤率 (%) | -26.446 | -8.999 | -8.490 | 10.098 | 10.224 |
| 息稅前利潤/營業總收入 (%) | -23.203 | -8.073 | -10.362 | 9.347 | 8.542 |
| 淨利潤/營業總收入 (%) | -25.395 | -8.768 | -8.404 | 8.939 | 8.853 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 51.439 | 71.366 | -20.759 | 93.957 | 90.003 |
| 價值變動淨收益/利潤總額(%) | -1.718 | -3.313 | -3.337 | 5.218 | 6.823 |
| 營業外收支淨額/利潤總額(%) | 2.275 | 4.478 | 13.911 | -1.692 | -4.778 | 償債能力分析 |
| 流動比率 (X) | 1.969 | 1.727 | 1.674 | 2.503 | 2.087 |
| 速動比率 (X) | 1.133 | 0.950 | 0.885 | 1.613 | 1.239 |
| 資產負債率 (%) | 44.478 | 45.897 | 47.289 | 39.723 | 25.567 |
| 帶息債務/全部投入資本 (%) | 33.317 | 34.244 | 34.950 | 30.232 | 10.435 |
| 股東權益/帶息債務 (%) | 190.517 | 183.024 | 177.501 | 224.801 | 836.847 |
| 股東權益/負債合計 (%) | 124.829 | 117.881 | 111.460 | 151.744 | 291.124 |
| 利息保障倍數 (X) | -6.012 | -5.992 | 20.723 | -16.028 | -7.030 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 46.623 | 57.784 | 44.369 | 31.747 | 26.967 |
| 存貨周轉天數 (天) | 241.404 | 315.264 | 278.969 | 199.681 | 178.371 |
| 備註： | 即時報價更新時間為 07/09/2026 12:28 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
